The Congress
EHA Congress · Stockholm
Where European hematology meets face to face
Four days in Stockholm and online on new data across malignant and non-malignant hematology, gathering clinicians, researchers, nurses, patient advocates and partners.
4
days of sessions, posters and exhibition
3,493
participants from 45 countries
531
posters in two poster sessions
The 2026 edition
A congress built around science and conversation
The EHA2026 Congress took place on 11–14 June 2026 at Stockholmsmässan in Stockholm, and online.
The programme combined the opening ceremony, plenary and presidential sessions, abstract sessions, education and scientific working group sessions, two poster sessions, industry symposia and the exhibition.
Held each June, the Congress is the moment when European hematology takes stock of the year’s data and sets the questions for the year ahead.
Read the community's insightsThemes and programme
From the plenary hall to the poster hall
Invited lectures in the plenary hall; abstracts, education and discussion in the session rooms and poster halls, where peers from different fields compared notes.
Plenary and presidential sessions
Three themes from the main stage:
- Cell and gene therapy at the frontier
- Clonal hematopoiesis, aging and disease
- Equity of access to advanced therapies in Europe
Abstracts and education
Three ways the science was shared:
- 144 oral abstract presentations
- 531 posters in two poster sessions
- Education sessions accredited for CME
Highlights
What we heard at the Congress
Four threads from the 2026 programme, and the questions they leave for members.
976
abstracts submitted, from which the six highest-rated reached the plenary abstract session
Curing myeloma: a realistic goal?
The Presidential Symposium asked how far deep responses and new combinations can take patients with multiple myeloma.
Our question for members: what would a cure mean in your clinic?
Equity of access to advanced therapies
The Presidential Symposium looked at why patients in different European countries still reach CAR T-cell and gene therapies at different speeds.
Our question for members: what would make access fairer in your country?
Precision medicine in acute leukemia
The programme followed how genetic risk classification and targeted therapies change the treatment of acute leukemia.
Our question for members: where does precision medicine already change your decisions?
Speakers 2026
Seven perspectives from the main stage
Speakers of the plenary, presidential and award sessions in Stockholm in 2026.
Karin van Dijk
Leiden University Medical Center
Rocío Navarro
CNIO – Spanish National Cancer Research Centre
Andrew Ward
King's College Hospital
Andreas Meyer
Medical University of Graz
Takuya Tanaka
Keio University Hospital
Maya Levi
Sheba Medical Center
Luca Vitale
University of Turin – AOU Città della Salute
Who attends
Disciplines that rarely share a room
Clinicians, laboratory and clinical researchers, nurses, trainees, patient advocates, national hematology societies and industry partners.
What sets the EHA Congress apart is that every part of hematology shares one programme, so a transplant physician and a laboratory scientist can compare notes on the same patients.
The Congress is intended for medical professionals and is not open to the general public. Patient advocates are welcome in the scientific sessions.
See how members take part